183 General discussion 7 1. Abbafati C, Abbas KM, Abbasi-Kangevari M, Abd-Allah F, Abdelalim A, Abdollahi M, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet. 2020;396(10258):1204–22. 2. Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study. Vol. 76, Journal of the American College of Cardiology. Elsevier Inc.; 2020. p. 2982–3021. 3. Khan MA, Hashim MJ, Mustafa H, Baniyas MY, Al Suwaidi SKBM, AlKatheeri R, et al. Global Epidemiology of Ischemic Heart Disease: Results from the Global Burden of Disease Study. Cureus. 2020 Jul 23; 4. Wang C, Sun Y, Jiang D, Wang C, Liu S. Risk-attributable burden of ischemic heart disease in 137 low-and middleincome countries from 2000 to 2019. J Am Heart Assoc. 2021 Oct 5;10(19). 5. Visseren FLJ, MacH F, Smulders YM, Carballo D, Koskinas KC, Bäck M, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42(34):3227–337. 6. Johansson S, Rosengren A, Young K, Jennings E. Mortality and morbidity trends after the first year in survivors of acute myocardial infarction: A systematic review. BMC Cardiovasc Disord. 2017 Feb 7;17(1). 7. Nedkoff L, Briffa T, Murray K, Gaw J, Yates A, Sanfilippo FM, et al. Risk of early recurrence and mortality in highrisk myocardial infarction patients: A population-based linked data study. International Journal of Cardiology: Cardiovascular Risk and Prevention. 2023 Jun 1;17. 8. Okkonen M, Havulinna AS, Ukkola O, Huikuri H, Pietilä A, Koukkunen H, et al. Risk factors for major adverse cardiovascular events after the first acute coronary syndrome. Ann Med. 2021;53(1):817–23. 9. Jernberg T, Hasvold P, Henriksson M, Hjelmm H, Thuresson M, Janzon M. Cardiovascular risk in post-myocardial infarction patients: nationwide real world data demonstrate the importance of a long-term perspective. Eur Heart J. 2015;36:1163–70. 10. Vedin O, Hagström E, Stewart R, Brown R, Krug-Gourley S, Davies R, et al. Secondary prevention and risk factor target achievement in a global, high-risk population with established coronary heart disease: Baseline results from the STABILITY study. Eur J Prev Cardiol. 2013 Aug;20(4):678–85. 11. Kotseva K, De Backer G, De Bacquer D, Rydén L, Hoes A, Grobbee D, et al. Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry. Eur J Prev Cardiol. 2019;26(8):824–35. 12. Murphy A, Palafox B, O’Donnell O, Stuckler D, Perel P, AlHabib KF, et al. Inequalities in the use of secondary prevention of cardiovascular disease by socioeconomic status: evidence from the PURE observational study. Lancet Glob Health. 2018 Mar 1;6(3):e292–301. 13. Avezum A, Oliveira GBF, Lanas F, Lopez-Jaramillo P, Diaz R, Miranda JJ, et al. Secondary CV Prevention in South America in a Community Setting: The PURE Study. Glob Heart. 2017;12(4):305–13. 14. Zhao M, Vaartjes I, Graham I, Grobbee D, Spiering W, Klipstein-Grobusch K, et al. Sex differences in risk factor management of coronary heart disease across three regions. Heart. 2017;103(20):1587–94. 15. Vynckier P, Ferrannini G, Ryden L, Jankowski P, De Backer T, Gevaert S, et al. Gender gap in risk factor control of coronary patients far from closing: Results from the European Society of Cardiology EUROASPIRE V registry. Eur J Prev Cardiol. 2022 Jan 1;29(2):344–51. 16. Schultz WM, Kelli HM, Lisko JC, Varghese T, Shen J, Sandesara P, et al. Socioeconomic status and cardiovascular outcomes: Challenges and interventions. Circulation. 2018;137(20):2166–78. 17. Bruthans J, Mayer O, De Bacquer D, De Smedt D, Reiner Z, Kotseva K, et al. Educational level and risk profile and risk control in patients with coronary heart disease. Eur J Prev Cardiol. 2016;23(8):881–90. 18. Minneboo M, Lachman S, Snijder MB, Vehmeijer JT, Jørstad HT, Peters RJG. Risk factor control in secondary prevention of cardiovascular disease: results from the multi-ethnic HELIUS study. Netherlands Heart Journal. 2017 Apr 8;25(4):250–7. 19. Bruthans J, Mayer O, De Bacquer D, De Smedt D, Reiner Z, Kotseva K, et al. Educational level and risk profile and risk control in patients with coronary heart disease. Eur J Prev Cardiol. 2016 May 1;23(8):881–90. 20. Ghisi GL de M, Chaves GS da S, Britto RR, Oh P. Health literacy and coronary artery disease: A systematic review. Vol. 101, Patient Education and Counseling. Elsevier Ireland Ltd; 2018. p. 177–84. 21. Peltzer S, Hellstern M, Genske A, Jünger S, Woopen C, Albus C. Health literacy in persons at risk of and patients with coronary heart disease: A systematic review. Vol. 245, Social Science and Medicine. Elsevier Ltd; 2020. 22. Tchicaya A, Lorentz N, Demarest S, Beissel J. Persistence of socioeconomic inequalities in the knowledge of cardiovascular risk factors five years after coronary angiography. European Journal of Cardiovascular Nursing. 2018 Feb 1;17(2):136–47. REFERENCES
RkJQdWJsaXNoZXIy MTk4NDMw